Women in criminal justice system less likely to receive evidence-based treatment for opioid use disorder
May. 18, 2020—Pregnant women involved in the criminal justice system are disproportionately not receiving medications for opioid use disorder, as compared to their peers, according to a Vanderbilt-led study published today in PLOS Medicine.
May. 12, 2020—Rates of neonatal abstinence syndrome (NAS) have plateaued after 20 years of increasing frequency across the country, according to a new study published in Health Affairs. NAS is a withdrawal syndrome experienced by some opioid-exposed newborns after birth.
Safeguarding opioids a concern as children may have more access with families at home due to COVID-19
Apr. 22, 2020—A new poll from the Vanderbilt Center for Child Health Policy found that few Tennessee parents take steps to safeguard opioids at home, an important concern when children are spending more time indoors due to COVID-19 social distancing recommendations.
Dec. 12, 2019—Vanderbilt University Medical Center, through the offices of its Opioid Oversight Executive Committee, is offering its employees an online tutorial, Opioid Laws — Prescribing at VUMC
Dec. 5, 2019—The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.
Aug. 29, 2019—Most women who undergo a cesarean section are sent home with more opioids than they need, but a significant proportion of women use all opioids and report unmet pain needs, according to Sarah Osmundson, MD, MS, assistant professor of Obstetrics and Gynecology.
Jul. 1, 2019—Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone.
May. 2, 2019—New Bridge Clinic links patients with substance use disorder to follow-up care upon discharge.